BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38556560)

  • 21. Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancer.
    Chen P; Zhao L; Wang H; Zhang L; Zhang W; Zhu J; Yu J; Zhao S; Li W; Sun C; Wu C; He Y; Zhou C
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34362829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential protein-coding gene and long noncoding RNA expression in smoking-related lung squamous cell carcinoma.
    Li S; Sun X; Miao S; Liu J; Jiao W
    Thorac Cancer; 2017 Nov; 8(6):672-681. PubMed ID: 28949095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrative Analysis of Ferroptosis-Related Genes in Small Cell Lung Cancer for the Identification of Biomarkers and Therapeutic Targets.
    Yunchu Y; Miyanaga A; Seike M
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):125. PubMed ID: 37395033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.
    Horn L; Reck M; Spigel DR
    Oncologist; 2016 Aug; 21(8):910-21. PubMed ID: 27354668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer.
    Song Y; Sun Y; Sun T; Tang R
    Comb Chem High Throughput Screen; 2020; 23(5):381-391. PubMed ID: 32264809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution.
    Dora D; Rivard C; Yu H; Bunn P; Suda K; Ren S; Lueke Pickard S; Laszlo V; Harko T; Megyesfalvi Z; Moldvay J; Hirsch FR; Dome B; Lohinai Z
    Mol Oncol; 2020 Sep; 14(9):1947-1965. PubMed ID: 32506804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics.
    Li Y; Zhou X; Lyu Z
    Open Med (Wars); 2023; 18(1):20230806. PubMed ID: 37808164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
    Cao Y; Zhu W; Chen W; Wu J; Hou G; Li Y
    Dis Markers; 2019; 2019():5451290. PubMed ID: 31093306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
    Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
    Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer.
    Kim KB; Kim Y; Rivard CJ; Kim DW; Park KS
    Cancer Res; 2020 Nov; 80(22):5051-5062. PubMed ID: 32973083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.
    Udyavar AR; Hoeksema MD; Clark JE; Zou Y; Tang Z; Li Z; Li M; Chen H; Statnikov A; Shyr Y; Liebler DC; Field J; Eisenberg R; Estrada L; Massion PP; Quaranta V
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S1. PubMed ID: 24564859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The identification of a two-gene prognostic model based on cisplatin resistance-related ceRNA network in small cell lung cancer.
    Zhang Y; Zhu Q; Qi J; Fu M; Xu A; Wang W; Wang H; Nie J; Hong B
    BMC Med Genomics; 2023 May; 16(1):103. PubMed ID: 37189142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival in extensive-stage small-cell lung cancer treated with different immune checkpoint inhibitors in multiple-line therapies: A case report and literature review.
    Zhang X; Zheng J; Niu Y; Xue C; Yu Y; Tan K; Cui H
    Front Immunol; 2022; 13():1059331. PubMed ID: 36532013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knocking down the expression of Aurora-A gene inhibits cell proliferation and induces G2/M phase arrest in human small cell lung cancer cells.
    Lu Y; Liu Y; Jiang J; Xi Z; Zhong N; Shi S; Wang J; Wei X
    Oncol Rep; 2014 Jul; 32(1):243-9. PubMed ID: 24841948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.
    Stumpf C; Kaemmerer D; Neubauer E; Sänger J; Schulz S; Lupp A
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1921-1932. PubMed ID: 30076481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition.
    Li D; Tong Q; Lian Y; Chen Z; Zhu Y; Huang W; Wen Y; Wang Q; Liang S; Li M; Zheng J; Liu Z; Liu H; Guo L
    Cancer Res Treat; 2021 Oct; 53(4):1042-1056. PubMed ID: 33705625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.
    Yokouchi H; Nishihara H; Harada T; Ishida T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Higuchi M; Honjo O; Minami Y; Watanabe N; Goto A; Suzuki H; Dosaka-Akita H; Isobe H; Nishimura M; Munakata M
    Oncotarget; 2017 Jun; 8(24):39711-39726. PubMed ID: 28055980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.
    Song Y; Tang W; Li H
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33398330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
    Ragavan M; Das M
    Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.